Rheumnow Podcast
Dr. Cush
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
Mentioned books
Aug 1, 2025 • 18min
A New RA Approval (8.1.2025)
Dr. Jack Cush reviews the news, journal reports and a new treatment for RA from the FDA.
Jul 25, 2025 • 23min
CKD & Osteoporosis Rx Revisited (7.25.2025)
Dr. Jack Cush reviews the news, journal and FDA updates from this past week on RheumNow.com
Jul 18, 2025 • 29min
NHANES, Numbers, & Risk (7.18.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Interesting case questions from "Ask Cush Anything"
Jul 11, 2025 • 26min
Hmmm Really? (7.11.2025)
Dr. Jack Cush reviews the news and journal reports from this past week - some obvious, other new thoughts and some - hmmm, reallly?
Jun 27, 2025 • 22min
PCR- Prevalence, Cost, & Risk (6.27.2025)
Dr. Jack Cush reviews the news and journal reports from last week on RheumNow.com
Jun 25, 2025 • 59min
EULAR 2025 Rheumatology RoundUp Hosted by Dr. John J. Cush and Dr. Arthur Kavanaugh
Join rheumatology experts Dr. John J. Cush and Dr. Arthur Kavanaugh for the EULAR Rheumatology RoundUp — a dynamic, fast-paced discussion capturing the most impactful highlights, late-breaking data, and clinical takeaways from EULAR 2025.
Jun 24, 2025 • 54min
EULAR 2025 - Day 9 podcast
Trends and Innovations from Barcelona (6.20.2025)
AI Advances axSpA Diagnosis with Multimodal MRI
IL-17 Inhibitors in Psoriatic Arthritis
IL-17 Inhibitors for Axial Spondyloarthritis
New IL-17 Inhibition New Molecular Constructs
Jun 20, 2025 • 28min
Trends and Innovations from Barcelona (6.20.2025)
Jun 20, 2025 • 40min
EULAR 2025 - Day 8 podcast
Resilience or Resignation? Rethinking Pain, Aging, and Quality of Life
Spondyloarthritis Panel: Eular 2025
Jun 19, 2025 • 37min
EULAR 2025 – SpA Panel Discussion
Leading rheumatology experts discuss the latest research, treatment advances, and clinical insights in axial spondyloarthritis. Hear what’s new from EULAR 2025 and what it means for improving patient outcomes.
